C-4 sterol methyl oxidase encoded by the ERG25 gene is a key enzyme in the ergosterol biosynthetic pathway in fungi. ERG25p contains three histidine clusters common to nonheme iron binding enzymes and endoplasmic reticulum retrieval signal. In order to characterize ERG25p, we generated a series of temperature-sensitive(ts) erg25 mutants by random mutagenesis.
C-4 sterol methyl oxidase encoded by the ERG25 gene is a key enzyme in the ergosterol biosynthetic pathway in fungi. ERG25p contains three histidine clusters common to nonheme iron binding enzymes and endoplasmic reticulum retrieval signal. In order to characterize ERG25p, we generated a series of temperature-sensitive(ts) erg25 mutants by random mutagenesis.
One of the resulting mutants, the mERG25 strain, accumulated 4,4-dimethlzymosterol at the nonpermissive temperature. Sequence analysis of the mERG25 mutant indicated three amino acid substitutions in ERG25p, namely N48D, V133A, and F135S. These results indicate that the ERG25 gene product is a new antifungal target.
The ergosterol biosynthetic pathway is the target of the major classes of antifungal drugs currently used to treat human systemic fungal infections. Among these antifungals, fluconazole is widely used because it dose not cause serious side effects. Recently, however, the emergence of fluconazole-resistant organisms is compromising the reliability of this agent. Thus, the pharmaceutical industry now faces an urgent need to develop novel compounds and new antifungal target sites. In Saccharomyces cerevisiae, all of the genes encoding ergosterol biosynthetic enzymes have been cloned and characterized1). Earlier studies have demonstrated that all of the genes prior to the sterol C-24 methyltransferase (ERG6) gene are essential for viability, hence these genes have the potential to be singled out as new targets for the discovery of novel antifungal drugs. For example, C-14 reductase (ERG24p) is inhibited by a series of morpholines now employed as agricultural fungicides2,3). Squalene epoxidase (ERG 1 p) is inhibited by terbinafine, an agent used as a topical medication for mycoses of the skin4,5). Lanosterol
Inhibitors of the C-4 demethylation step have not been previously reported. C-4 demethylation is separated into three reactions: (I) a C-4 methyloxidase reaction in which aldehyde, and finally to a carboxylic acid, (II) a C-3 sterol to the decarboxylation of a 3-ketocarboxylic acid sterol intermediate, (III) a 3-keto reduction, which converts the ERG27 genes were cloned as the genes concerned with each step7-9 The plasmids pRD415 and pRD416 were constructed in our laboratory from pRS415 and pRS416, respectively12).
pRD415 is a yeast centromere vector that consists of the S. cerevisiae GPD1 promoter region13), a multiple cloning site, the S. cerevisiae CYC1 transcription termination signal, and the LEU2 gene as a selectable marker. The only difference between pRD416 and pRD415 is that the former includes the URA3 gene as a selectable marker. A 1.0-kb fragment containing the coding sequence for ERG25 was amplified by PCR using strain FL100 genomic DNA as a template and the primers ERG25-3 and ERG25-4 shown in Table 2 . The ERG25-3 and ERG25-4 primers were designed to contain the recognition sites for HindIII and XhoI site, respectively (italic letters in Table 2 ). The PCR product was digested with HindIII and XhoI and ligated into plasmids pRD415 and pRD416, resulting in the formation of pRD415-ERG25 and pRD416-ERG25, respectively.
Construction of the Yeast Strain dERG25
The mutant with erg25 gene disruption was constructed by the method of LORENZ et al.14) with some modification, and the yeast transformations were performed according to the method of ITO et al. 15 ). The plasmid pRD416-ERG25 was transformed into the haploid strain PDR5 (Table 1 ).
The resulting Ura+ colonies, termed sERG25, were isolated and used to disrupt the chromosomal ERG25 gene ( Figure   1 ). The chimera erg25::HIS3 gene was amplified by PCR using the primers erg25::HIS-3 and erg25::HIS-4. The underlined residues in Table 2 indicate nucleotides homologous to HIS3 selectable marker. The amplified 1,110 by fragment was introduced to the sERG25 strain.
The His+ transformants were isolated and examined by PCR to determine whether the interrupted erg25 gene was integrated into the chromosome by homologous recombination, thereby satisfying the precondition for obtaining the strain dERG25 (erg25:: HIS3 pRD416-ERG25).
Isolation of the Temperature-sensitive mERG25 Strain
To construct pRD415-mERG25, mutagenic PCR was performed as previously described16). The ERG25 gene was amplified using pRD416-ERG25 as a template and primers ERG25-3 and ERG25-4. The PCR product was digested with HindIII and XhoI and ligated into plasmid pRS415.
Mutagenized plasmids were transformed into the dERG25 
Results

Isolation of the Temperature-sensitive mERG25 Strain
To construct the is erg25 mutants, we prepared dERG25, a strain, in which the chromosome ERG25 gene locus was completely disrupted by the HIS3 gene, but the cell was rescued by the plasmid pRD416-ERG25 containing a single yeast ERG25 gene (Fig. 1) . This dERG25 strain failed to grow on media containing 5-FOA, a reagent that selectively kills the URA3 cells. Thus, the growth of the dERG25 strain depended on the plasmid pRD416-ERG25, and this was confirmed by PCR analyses (data not shown). Using dERG25 strain, we isolated the is erg25 strains. The method is summarized in Figure 2 . medium. The wild-type ssERG25 strain showed an identical sterol profile at both temperatures (Fig. 3 a, b) . The was identical to that of the wild-type strain, but notably the mERG25 strain produced another sterol different from ergosterol and lanosterol at the nonpermissive temperature (Fig. 3 c, d ). The another sterol (retention time, 15.117 minutes) was confirmed to be 4,4-dimethylzymosterol by its mass spectrum and 13C NMR. The molecular ion was observed at 412 Da and the fragmentation pattern was identical to the spectrum of 4,4-dimethylzymosterol18).
Sequence analysis of the mERG25 mutant indicated that the bases at position 142, 390, and 404 were changed from an A to a G, a T to a G, and a T to a C, respectively, resulting in three amino acid substitutions, i.e., N48D, V133A, and F135S, in the ERG25p (Fig. 4) .
Discussion
Sterols are known to be important in membrane fluidity, membrane permeability, cell morphology, enzyme activity, and cell cycle progression. Therefore, the enzymes of the ergosterol biosynthetic pathway are likely to offer unique demethylase (ERG 11p).
The ERG25 gene from S. cerevisiae has been cloned and characterized previously7). An amino acid sequence analysis showed that the ERG25p was a membrane protein localized in the endoplasmic reticulum. ERG25p is an important enzyme that catalyzes the first reaction that remove the two methyl groups from the C-4 position of 4,4-dimethylzymosterol. The ERG25p contains three histidine motiefs, H159RLFH, H172KQHH, and H256HDLHHH. These motifs are common to iron-binding, nonheme integral membrane desaturases, hydroxylases, and oxidases. It was surmised that three histidine motifs in these enzymes act as ligands for the iron atom(s).
In this report, we constructed the is mutant of S. cerevisiae and identified the is mutations of S. cerevisiae ERG25 gene. Three amino acid substitutions occurred in our is mutant strain of S. cerevisiae, N48D, V133A, and F135S. MATTHEW et al. isolated a ts mutation of the C.
albicans ERG25 gene and identified the amino acid substitution N247D within the region of histidine clusters19). They reported that the amino acid change at this position was between histidine clusters and could involve the inability of the altered ERG25p to bind iron. The mERG25 strain of S. cerevisiae had another mutation of the ERG25 gene. The amino acid changes were located 
